UnitedHealthcare Includes Sight Sciences OMNI System in Covered Glaucoma Surgery Options
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Sep 09 2025
0mins
Should l Buy UNH?
Source: Benzinga
UnitedHealthcare Policy Update: UnitedHealthcare has expanded its coverage to include goniotomy, trabeculotomy, canaloplasty, and combined procedures for adults with mild to moderate open-angle glaucoma and cataracts, effective October 1, 2025.
Sight Sciences Financial Performance: Sight Sciences reported a second-quarter loss of 23 cents per share, better than expected, with sales of $19.56 million, leading to an increase in fiscal 2025 sales guidance to $72 million-$76 million.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy UNH?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on UNH
Wall Street analysts forecast UNH stock price to rise
19 Analyst Rating
16 Buy
3 Hold
0 Sell
Strong Buy
Current: 294.930
Low
330.00
Averages
397.82
High
444.00
Current: 294.930
Low
330.00
Averages
397.82
High
444.00
About UNH
UnitedHealth Group Incorporated is a healthcare and well-being company. Its segments include Optum Health, Optum Insight, Optum Rx, and UnitedHealthcare, which includes UnitedHealthcare Employer & Individual, UnitedHealthcare Medicare & Retirement and UnitedHealthcare Community & State. Optum Health offers comprehensive and patient-centered care, addressing the physical, mental, social, and financial well-being. Optum Health delivers primary, specialty and surgical care; helps patients and providers navigate and address complex, chronic and behavioral health needs. Optum Insight connects the healthcare system with services, analytics and platforms that make clinical, administrative and financial processes simpler and more efficient for all participants in the healthcare system. Optum Rx offers a range of pharmacy care services through retail pharmacies, through home delivery, specialty and community health pharmacies and the provision of in-home and community-based infusion services.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
UnitedHealth Group Faces Significant Challenges Amid Rising Costs
- Rising Medical Care Ratio: UnitedHealth Group's medical care ratio reached 89.1% in 2025, up from 85.5% in 2024, indicating increasing pressure on the company's ability to manage medical expenses, which could adversely affect profitability.
- Significant Stock Decline: Over the past 12 months, UnitedHealth's stock has fallen by 37%, dropping from a 52-week high of $606 to around $293, reflecting market concerns about its future growth amid rising costs and billing investigations.
- Investor Confidence Eroding: Although the company offers a 3% above-average dividend yield, the uncertainty surrounding its business prospects has weakened investor confidence in the dividend, potentially leading to capital outflows and further stock price declines.
- Uncertain Future Growth: The future growth of UnitedHealth Group hinges on its ability to effectively reduce the medical care ratio; without significant improvement, investor skepticism regarding its profit growth potential may increase.
See More
UnitedHealth Plans to Sell Securities Amid Revenue Decline
- Securities Sale Plan: UnitedHealth (UNH) announced plans to sell a range of securities through a 'shelf' process, including debt, preferred stock, and common stock, which is expected to significantly impact its financing structure.
- Clear Use of Proceeds: The company stated that the proceeds from the offerings will be used for debt refinancing, stock buybacks, acquisitions, and other general corporate purposes, demonstrating a proactive approach to financial management.
- Revenue Decline Outlook: UnitedHealth projects its first annual revenue decline in decades, with cash and cash equivalents at $24.4 billion as of December 31, 2025, indicating a ~4% year-over-year drop, reflecting challenges in the market environment.
- Negative Market Reaction: Following four consecutive sessions of gains, UnitedHealth's stock slipped approximately 2% in premarket trading, indicating investor concerns regarding the company's future financial health.
See More
Surge in Options Volume for UnitedHealth Group and Cheniere Energy
- UnitedHealth Options Activity: Today, UnitedHealth Group (UNH) options volume reached 49,795 contracts, equivalent to approximately 5 million shares, representing 53.4% of its average daily trading volume over the past month, indicating strong investor interest in the stock.
- High Volume Insights: Within UNH, the $300 strike call option has seen particularly high activity, with 6,540 contracts traded today, representing about 654,000 shares, reflecting market expectations for future price increases.
- Cheniere Energy Options Dynamics: Concurrently, Cheniere Energy (LNG) options also showed robust activity, with a volume of 9,939 contracts, equivalent to approximately 993,900 shares, also accounting for 53.4% of its average daily trading volume over the past month, highlighting market attention on the company.
- Put Option Trading: For LNG, the $240 strike put option has recorded a trading volume of 2,087 contracts, representing about 208,700 shares, indicating a cautious stance among investors regarding potential future price declines.
See More
UnitedHealth Group Stock Faces Significant Decline Amid Rising Costs
- Stock Decline: UnitedHealth Group's stock has fallen by 37% over the past year, dropping from a 52-week high of $606 to around $293, indicating market concerns about its future profitability.
- Rising Medical Care Ratio: The medical care ratio reached 89.1% in 2025, up from 85.5% in 2024, highlighting the company's challenges in controlling costs, which could impact its profit growth outlook.
- Investigations Impact: The company is facing investigations into its billing practices, which may negatively affect future growth and increase uncertainty for investors, putting pressure on the stock price.
- Dividend Attractiveness Declining: Although the stock offers a 3% dividend yield, investor confidence in the dividend may wane if the underlying business performance falters, prompting a more cautious investment approach.
See More
Analysis of Significant Stock Movements
- AeroVironment Stock Decline: AeroVironment shares fell approximately 20% after Raymond James downgraded its rating from strong buy to underperform, losing exclusivity on a $1.4 billion contract with the U.S. Space Force, which could negatively impact future revenues.
- Palantir Sales Surge: Palantir's stock rose 6%, making it the biggest gainer in the S&P 500, with U.S. government revenue accounting for 41% of its sales in Q4, reflecting a 66% year-over-year increase, indicating potential growth from increased defense spending.
- Norwegian Cruise Line Earnings Guidance Cut: Norwegian Cruise Line shares dropped 10% due to weaker-than-expected earnings guidance for 2026, projecting earnings per share at $2.38, below the FactSet estimate of $2.57, raising concerns about its future profitability.
- AES Acquisition Announcement: AES shares plunged 17% after a consortium led by BlackRock announced plans to acquire the company for nearly $11 billion, offering shareholders $15 per share in cash, with the deal expected to close in late 2026 or early 2027.
See More
Defense Stocks Rise After U.S.-Israeli Strikes on Iran
- Defense Stocks Surge: Following the joint U.S.-Israeli attack on Iran, defense stocks collectively rose, with Lockheed Martin shares gaining 6%, Northrop Grumman up 5%, and drone manufacturer AeroVironment soaring over 10%, indicating strong market optimism regarding defense spending.
- Oil Prices Spike: The escalation of conflict has led to a significant rise in oil prices, with Brent crude hitting a 52-week high of over $78 on Monday, causing Exxon Mobil and Chevron shares to rise about 4% and ConocoPhillips to gain over 5%, reflecting market concerns over potential disruptions to global crude production and transport.
- Tankers Stocks Perform Well: In response to the military strikes in the Middle East, tanker stocks surged, with Frontline rising over 5%, DHT Holdings up 7%, and International Seaways increasing by 6%, showcasing heightened expectations for tanker transportation demand.
- Travel Stocks Decline: The conflict has caused oil prices to surge, disrupting global travel, leading to declines in travel stocks, with Expedia and Booking Holdings down 3.2% and 2.7%, respectively, Delta Air Lines falling 5.7%, and American Airlines and United Airlines dropping at least 6%, reflecting a pessimistic outlook for the travel industry.
See More
UnitedHealth Group Faces Significant Challenges Amid Rising Costs
- Rising Medical Care Ratio: UnitedHealth Group's medical care ratio reached 89.1% in 2025, up from 85.5% in 2024, indicating increasing pressure on the company's ability to manage medical expenses, which could adversely affect profitability.
- Significant Stock Decline: Over the past 12 months, UnitedHealth's stock has fallen by 37%, dropping from a 52-week high of $606 to around $293, reflecting market concerns about its future growth amid rising costs and billing investigations.
- Investor Confidence Eroding: Although the company offers a 3% above-average dividend yield, the uncertainty surrounding its business prospects has weakened investor confidence in the dividend, potentially leading to capital outflows and further stock price declines.
- Uncertain Future Growth: The future growth of UnitedHealth Group hinges on its ability to effectively reduce the medical care ratio; without significant improvement, investor skepticism regarding its profit growth potential may increase.
See More
UnitedHealth Plans to Sell Securities Amid Revenue Decline
- Securities Sale Plan: UnitedHealth (UNH) announced plans to sell a range of securities through a 'shelf' process, including debt, preferred stock, and common stock, which is expected to significantly impact its financing structure.
- Clear Use of Proceeds: The company stated that the proceeds from the offerings will be used for debt refinancing, stock buybacks, acquisitions, and other general corporate purposes, demonstrating a proactive approach to financial management.
- Revenue Decline Outlook: UnitedHealth projects its first annual revenue decline in decades, with cash and cash equivalents at $24.4 billion as of December 31, 2025, indicating a ~4% year-over-year drop, reflecting challenges in the market environment.
- Negative Market Reaction: Following four consecutive sessions of gains, UnitedHealth's stock slipped approximately 2% in premarket trading, indicating investor concerns regarding the company's future financial health.
See More
Surge in Options Volume for UnitedHealth Group and Cheniere Energy
- UnitedHealth Options Activity: Today, UnitedHealth Group (UNH) options volume reached 49,795 contracts, equivalent to approximately 5 million shares, representing 53.4% of its average daily trading volume over the past month, indicating strong investor interest in the stock.
- High Volume Insights: Within UNH, the $300 strike call option has seen particularly high activity, with 6,540 contracts traded today, representing about 654,000 shares, reflecting market expectations for future price increases.
- Cheniere Energy Options Dynamics: Concurrently, Cheniere Energy (LNG) options also showed robust activity, with a volume of 9,939 contracts, equivalent to approximately 993,900 shares, also accounting for 53.4% of its average daily trading volume over the past month, highlighting market attention on the company.
- Put Option Trading: For LNG, the $240 strike put option has recorded a trading volume of 2,087 contracts, representing about 208,700 shares, indicating a cautious stance among investors regarding potential future price declines.
See More
UnitedHealth Group Stock Faces Significant Decline Amid Rising Costs
- Stock Decline: UnitedHealth Group's stock has fallen by 37% over the past year, dropping from a 52-week high of $606 to around $293, indicating market concerns about its future profitability.
- Rising Medical Care Ratio: The medical care ratio reached 89.1% in 2025, up from 85.5% in 2024, highlighting the company's challenges in controlling costs, which could impact its profit growth outlook.
- Investigations Impact: The company is facing investigations into its billing practices, which may negatively affect future growth and increase uncertainty for investors, putting pressure on the stock price.
- Dividend Attractiveness Declining: Although the stock offers a 3% dividend yield, investor confidence in the dividend may wane if the underlying business performance falters, prompting a more cautious investment approach.
See More
Analysis of Significant Stock Movements
- AeroVironment Stock Decline: AeroVironment shares fell approximately 20% after Raymond James downgraded its rating from strong buy to underperform, losing exclusivity on a $1.4 billion contract with the U.S. Space Force, which could negatively impact future revenues.
- Palantir Sales Surge: Palantir's stock rose 6%, making it the biggest gainer in the S&P 500, with U.S. government revenue accounting for 41% of its sales in Q4, reflecting a 66% year-over-year increase, indicating potential growth from increased defense spending.
- Norwegian Cruise Line Earnings Guidance Cut: Norwegian Cruise Line shares dropped 10% due to weaker-than-expected earnings guidance for 2026, projecting earnings per share at $2.38, below the FactSet estimate of $2.57, raising concerns about its future profitability.
- AES Acquisition Announcement: AES shares plunged 17% after a consortium led by BlackRock announced plans to acquire the company for nearly $11 billion, offering shareholders $15 per share in cash, with the deal expected to close in late 2026 or early 2027.
See More
Defense Stocks Rise After U.S.-Israeli Strikes on Iran
- Defense Stocks Surge: Following the joint U.S.-Israeli attack on Iran, defense stocks collectively rose, with Lockheed Martin shares gaining 6%, Northrop Grumman up 5%, and drone manufacturer AeroVironment soaring over 10%, indicating strong market optimism regarding defense spending.
- Oil Prices Spike: The escalation of conflict has led to a significant rise in oil prices, with Brent crude hitting a 52-week high of over $78 on Monday, causing Exxon Mobil and Chevron shares to rise about 4% and ConocoPhillips to gain over 5%, reflecting market concerns over potential disruptions to global crude production and transport.
- Tankers Stocks Perform Well: In response to the military strikes in the Middle East, tanker stocks surged, with Frontline rising over 5%, DHT Holdings up 7%, and International Seaways increasing by 6%, showcasing heightened expectations for tanker transportation demand.
- Travel Stocks Decline: The conflict has caused oil prices to surge, disrupting global travel, leading to declines in travel stocks, with Expedia and Booking Holdings down 3.2% and 2.7%, respectively, Delta Air Lines falling 5.7%, and American Airlines and United Airlines dropping at least 6%, reflecting a pessimistic outlook for the travel industry.
See More
